Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

MRI Biomarkers in ALS

NCT02405182

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +10 more
Locations
  • University of Calgary / Heritage Medical Research Clinic Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • University of British Columbia / GF Strong Rehab Centre Vancouver, British Columbia, Canada
  • Western University / London Health Sciences Centre London, Ontario, Canada
View Trial Details
Completed

Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

NCT00545974

Conditions
Brain Diseases, Central Nervous System Diseases, Cognition Disorders, +15 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University California, San Francisco San Francisco, California, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Completed

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT00790582

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • UCLA Neuromuscular Research Center Los Angeles, California, United States
  • UC Irvine MDA/ALS & Neuromuscular Center Orange, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View Trial Details
Completed

Flortaucipir PET Imaging in Subjects With FTD

NCT03040713

Conditions
Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
Locations
  • Movement Disorder Center, UCSD La Jolla, California, United States
  • Memory and Aging Center, UCSF San Francisco, California, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT03160898

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • St. Joseph's Hospital and Medical Center - Barrow Neurological Clinics Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • Forbes Norris MDA/ALS Research Center San Francisco, California, United States
View all 64 locations
View Trial Details
Completed

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

NCT02496767

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • St. Joseph's Hospital & Medical Center - Barrow Neurology Clinics Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
View all 81 locations
View Trial Details

Related conditions